The effect of vascular endothelial growth factor (VEGF) on primary human cultured type 2 alveolar epithelial (AE2) cell proliferation

A. R. L. Medford, L. Armstrong, A. B. Millar (Bristol, United Kingdom)

Source: Annual Congress 2004 - Cellular injury and repair in the lung
Session: Cellular injury and repair in the lung
Session type: Oral Presentation
Number: 318

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. R. L. Medford, L. Armstrong, A. B. Millar (Bristol, United Kingdom). The effect of vascular endothelial growth factor (VEGF) on primary human cultured type 2 alveolar epithelial (AE2) cell proliferation. Eur Respir J 2004; 24: Suppl. 48, 318

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Vascular endothelial growth factor (VEGF) isoform expression in primary human cultured alveolar epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 84s
Year: 2003

Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro
Source: Eur Respir J 2002; 20: 1449-1456
Year: 2002



Effects of hypoxia on VEGF and VEGF-R expression by human alveolar epithelial (ATII) and human pulmonary microvascular endothelial (HMVEC-l) cells
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008

Production of a novel isoform of vascular endothelial growth factor (VEGF) by the normal human lung
Source: Eur Respir J 2006; 28: Suppl. 50, 822s
Year: 2006

Effect of dexamethasone on TNFα-induced expression of vascular endothelial growth factor (VEGF) in human airway smooth muscle cells - role of histone-acetylation
Source: Eur Respir J 2004; 24: Suppl. 48, 695s
Year: 2004

Imbalance between vascular endothelial growth factor and endostatin in emphysema
Source: Eur Respir J 2003 Oct 01;22(4):609-612
Year: 2003



Increased vascular endothelial growth factor (VEGF) secretion from activated T cells in COPD
Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly?
Year: 2007


Role of corticosteroids in TNFα-induced expression of vascular endothelial growth factor (VEGF) in human airway smooth muscle cells
Source: Annual Congress 2003 - Cell signalling and cytokines in asthma
Year: 2003


Keratinocyte growth factor-induced proliferation of rat airway epithelium is restricted to Clara cells in vivo
Source: Eur Respir J 2002; 20: 1185-1197
Year: 2002



Primary human airway epithelial cells inhibit proliferation of lung fibroblasts via transforming growth factor-β
Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight
Year: 2007


Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair
Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Year: 2008


Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo
Source: Eur Respir J 2011; 38: 939-946
Year: 2011



The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis.
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018



Oral presentation: Influenza virus (IV) impairs fibroblast growth factor receptor 2b (FGFR2b) dependent epithelial regeneration from a distal epithelial progenitor pool
Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Year: 2014

A role for vascular endothelial growth factor (VEGF) in fibrosis?
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009

The influence of sera from interstitial lung diseases (ILD) patients on human mononuclear cells (MNC) production of vascular endothelial growth factor (VEGF)
Source: Eur Respir J 2004; 24: Suppl. 48, 553s
Year: 2004

Increased binding activity of hypoxia inducible factor (HIF)-1α to vascular endothelial growth factor (VEGF) promoter region mediates enhanced vascular permeability in the lung of cystic fibrosis (CF) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 173s
Year: 2003

Expression of vascular endothelial growth factor (VEGF) and its receptors (VEFG-R1-Flt1, VEGF-R2-Flk1) in non small cell lung carcinomas (NSCLC): correlation with lymphangiogenesis and clinical outcome
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007


Expression of vascular endothelial growth factor (VEGF) and association with lymphangiogenesis in non small cell (NSCLC) and small cell lung carcinomas (SCLC)
Source: Eur Respir J 2006; 28: Suppl. 50, 386s
Year: 2006

Keratinocyte growth factor-induced proliferation of rat airway epithelium is restricted to Clara cells in vivo.
Source: Eur Respir J 2003; 21: 379
Year: 2003